CHEBI:31058 - (13R)-13-dihydrocarminomycin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name (13R)-13-dihydrocarminomycin
ChEBI ID CHEBI:31058
ChEBI ASCII Name (13R)-13-dihydrocarminomycin
Definition A anthracycline antibiotic that is a cardiotoxic metabolite of carminomycin obtained by formal reduction of the carbonyl group.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C26H29NO10
Net Charge 0
Average Mass 515.510
Monoisotopic Mass 515.17915
InChI InChI=1S/C26H29NO10/c1-9-21(30)13(27)6-16(36-9)37-15-8-26(35,10(2)28)7-12-18(15)25(34)20-19(23(12)32)22(31)11-4-3-5-14(29)17(11)24(20)33/h3-5,9-10,13,15-16,21,28-30,32,34-35H,6-8,27H2,1-2H3/t9-,10+,13-,15-,16-,21+,26-/m0/s1
InChIKey YXBSCYMMPXQFDS-LBIZDXDESA-N
SMILES C1(O)=C2C(C(C=3C(=CC=CC3O)C2=O)=O)=C(O)C4=C1C[C@](C[C@@H]4O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O)N)([C@@H](C)O)O
Roles Classification
Biological Role(s): cardiotoxic agent
A role played by a chemical compound exihibiting itself through the ability to induce damage to the heart and cardiomyocytes.
drug metabolite

antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via carbohydrate-containing antibiotic )
(via anthracycline antibiotic )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via anthracycline )
Application(s): antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing (13R)-13-dihydrocarminomycin (CHEBI:31058) has functional parent carminomycin (CHEBI:31359)
(13R)-13-dihydrocarminomycin (CHEBI:31058) has parent hydride tetracene (CHEBI:32600)
(13R)-13-dihydrocarminomycin (CHEBI:31058) has role antineoplastic agent (CHEBI:35610)
(13R)-13-dihydrocarminomycin (CHEBI:31058) has role cardiotoxic agent (CHEBI:50912)
(13R)-13-dihydrocarminomycin (CHEBI:31058) has role drug metabolite (CHEBI:49103)
(13R)-13-dihydrocarminomycin (CHEBI:31058) is a p-quinones (CHEBI:25830)
(13R)-13-dihydrocarminomycin (CHEBI:31058) is a aminoglycoside antibiotic (CHEBI:22507)
(13R)-13-dihydrocarminomycin (CHEBI:31058) is a anthracycline antibiotic (CHEBI:49322)
(13R)-13-dihydrocarminomycin (CHEBI:31058) is a tetracenequinones (CHEBI:51286)
(13R)-13-dihydrocarminomycin (CHEBI:31058) is conjugate base of (13R)-13-dihydrocarminomycin(1+) (CHEBI:140330)
Incoming (13R)-13-dihydrocarminomycin(1+) (CHEBI:140330) is conjugate acid of (13R)-13-dihydrocarminomycin (CHEBI:31058)
IUPAC Name
(1S,3S)-3,5,10,12-tetrahydroxy-3-[(1R)-1-hydroxyethyl]-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside
Synonyms Sources
Antibiotic 32999RP ChemIDplus
Carminomycinol ChemIDplus
Dihydrocarminomycin ChemIDplus
Dihydrokarminomycin ChemIDplus
RP-32999 ChemIDplus
Manual Xrefs Databases
C12431 KEGG COMPOUND
CPD-15736 MetaCyc
View more database links
Registry Number Type Source
62182-86-9 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
1037188 PubMed citation Europe PMC
623453 PubMed citation Europe PMC
6889513 PubMed citation Europe PMC
7083181 PubMed citation Europe PMC
7181464 PubMed citation Europe PMC
7251757 PubMed citation Europe PMC
7307236 PubMed citation Europe PMC
Last Modified
05 April 2018